换一批
换一批INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.
第一作者：
Christina,Stathopoulos
第一单位：
Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.
作者：
主题词
血管生成抑制剂(Angiogenesis Inhibitors);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);儿童(Child);儿童, 学龄前(Child, Preschool);女(雌)性(Female);荧光素血管造影术(Fluorescein Angiography);人类(Humans);婴儿(Infant);输注, 动脉内(Infusions, Intra-Arterial);输注, 静脉内(Infusions, Intravenous);玻璃体内注射(Intravitreal Injections);男(雄)性(Male);美法仑(Melphalan);显微镜检查, 声学(Microscopy, Acoustic);受体, 血管内皮生长因子(Receptors, Vascular Endothelial Growth Factor);重组融合蛋白质类(Recombinant Fusion Proteins);视网膜肿瘤(Retinal Neoplasms);视网膜新生血管化(Retinal Neovascularization);视网膜母细胞瘤(Retinoblastoma);回顾性研究(Retrospective Studies);托泊替坎(Topotecan);血管内皮生长因子A(Vascular Endothelial Growth Factor A)
DOI
10.1097/IAE.0000000000002339
PMID
30312257
发布时间
2020-09-11
- 浏览19
Retina (Philadelphia, Pa.)
2273-2282页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
